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ABSTRACT 
BACKGROUND AND OBJECTIVE: Millions of people suffer from pain worldwide, and annually, great economic 
costs are imposed on societies for pain relief. Analgesics such as alpha-2 adrenergic receptor agonists, which have low 
risk of complications, can be effective in assuaging pain and reducing costs. According to former studies, potassium 
channels play an important role in the analgesic mechanism of these receptors. This study aimed to determine the role 
of BK potassium channels in analgesia induced by alpha-2 adrenergic receptors. 
METHODS: This study was performed on 56 male Wistar rats weighing 250-300 g that were divided into seven 
groups of eight rats. We administered 0.7 mg/kg intraperitoneal (IP) injection of clonidine, 1 mg/kg IP injection of 
yohimbine, and 5 mg/kg intracerebroventricular (ICV) injection of yohimbine. Iberiotoxin at a dose of 100 nm was also 
injected ICV. Normal saline and DMSO were applied as solvents. Pain severity was evaluated using formalin test at a 
concentration of 2%.  
FINDINGS: The chronic pain induced by formalin injection was relieved by IP injection of 0.7 mg/kg clonidine. 
Moreover, 5 μg/kg and 1 μg/kg ICV administration of yohimbine with mean chronic pain scores of 2.29±0.13 and 
2.09±0.07, respectively, could significantly inhibit analgesic effect of clonidine with mean chronic pain score of 
1.55±0.14 (p<0.001). ICV injection of iberiotoxin with mean chronic pain score of 2.33±0.16 at a dose of 100 nm 
significantly diminished analgesic effects of clonidine.  
CONCLUSION: Alpha-2 adrenergic receptor agonists could induce analgesia in the animals, and the antagonist of this 
receptor inhibited the analgesic effect of agonists of these receptors. BK channel inhibition prevented analgesic effect 
of adrenergic receptor agonists, as well. 
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Introduction 
Alpha-2 adrenergic receptors are a member of the 
large family of adrenergic receptors, which act via 
binding to G inhibitory (Gi) proteins. Alpha-2 
adrenergic receptors have three subtypes namely, α2A,
α2B  and α2C (1). The subtypes of alpha-2 adrenergic 
receptor are widely distributed in the central and 
peripheral nervous systems (2-4). In general, alpha-2 
adrenergic receptor agonists are used for general 
anesthesia, critical care, treatment of hypertension and 
glaucoma, and reduction of morphine withdrawal 
symptoms (5, 6).  
Agonists of alpha-2 adrenergic receptors block 
nerve fibers, especially type C. In addition, they exert 
their analgesic effect through opioid and adenosine 
receptors (7). These receptors influence ionic 
conductivity by Gi stimulation or reduction of 
intracellular cAMP level (6, 7). According to various 
studies, clonidine, as an alpha-2-adrenergic receptor 
agonist, can alleviate pain (8-10). 
Potassium channel plays a major role in the 
analgesic mechanism of the alpha-2-adrenergic 
receptors (11), one of the most important of which is 
calcium-activated potassium channel (KCa). Based on 
conductance level, these channels are categorized as 
big (BK), intermediate (IK), and small (SK) 
conductance calcium-activated potassium channels 
(12). According to previous studies, BK potassium 
channels are associated with pain (13-15). It was also 
suggested that blockage of these channels in the spinal 
cord can cause neuropathic pain in rats (16). In a 
former study, it was reported that activation of 
potassium channels could promote analgesic effect of 
clonidine (17). 
Opening of potassium channels leads to outward 
potassium currents and in turn, hyperpolarization of 
cell membrane potential, which can also happen by 
alpha-2 adrenergic receptors on the potassium channels 
(18, 19). Understanding the role of potassium channels 
in the etiology of pain can provide deeper insight into 
pain treatment. Therefore, the present study aimed to 
determine the role of BK potassium channels in the 
analgesia caused by alpha-2 adrenergic receptor 
agonists using formalin test. 
Method 
This experimental study was performed on 56 
adult, male Wistar rats weighing 250-300 g, purchased 
from North Branch of Pasteur Institute, Iran. The 
animals were kept in separate cages at 20-22°C on a 
12:12-h light:dark cycle. The animals had free access 
to food and water with minimum stress. Moral 
considerations for minimizing pain in the animals were 
taken into account based on the Medical Ethics 
Committee principles and Laboratory Animal 
Management of Golestan University of Medical 
Sciences, Gorgan, Iran.  
In this study, the animals were randomly divided 
into seven groups of eight as follows: A) control 
group: the rats receiving 1 m/kg intraperitoneal (IP) 
injection of normal saline; B) clonidine group (alpha-2 
adrenergic receptor agonist): the rats receiving IP 
injection of clonidine (Sigma) at a dose of 0.7 mg/kg 
(volume: 1 mg/kg) (20); C) yohimbine group (alpha-2 
adrenergic receptor antagonist): IP+clonidine, IP 
injection of yohimbine (Tocris) at a dose of 1 mg/kg 
(21) and IP injection of clonidine five minutes later; D) 
DMSO group: intracerebroventricular (ICV) injections 
of 5 μl DMSO; E) ICV injection of yohimbine+ 
clonidine group: ICV injection of yohimbine at a dose 
of 5 μg/kg (21) and IP injection of clonidine five 
minutes later; F) iberiotoxin group (specific inhibitor 
of BK potassium channels): ICV injection of 
iberiotoxin (Tocris) at a dose of 100 nm (22); G) 
iberiotoxin+clonidine group: ICV injection of 
iberiotoxin and IP injection of clonidine five minutes 
later. 
The surgical procedure and cannulation of the 
lateral ventricle of the brain: The rats were 
anesthetized by IP injection of ketamine and xylazine 
(100 mg/kg and 10 mg/kg, respectively) combination. 
After anesthetization, the rats were placed in a 
stereotaxic apparatus with the head fixed. A flat-plate 
heater was placed under the animal's body, and their 
head was shaved. The animals’ eyes were kept wet 
during the surgery. The surgical field was disinfected 
by betadine. With respect to sterile principles, a 2-cm 
incision was made in the scalp using surgical blade 
number 22. Bleeding was prevented using cotton 
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swabs, and the protective layer of skull was slowly 
pushed aside so that the skull, bregma, and lambda 
regions as well as the brain fissures were obvious. 
Based on Rat Brain Atlas of Paxinos, the exact 
cannulation point was marked (at coordinates: AP=-
0.8, ML=1.5, and DV=-4.2) on the skin using 
stereotaxic apparetus. Using a dental drill, a hole was 
drilled through the skull (in the frontal bone) in the 
proximity of the guide cannula, and another hole was 
drilled in the occipital bone, and a dental screw was 
implanted in each of them. Thereafter, a hole was 
drilled in the marked area to insert the guide. A guide 
cannula (G 22) was unilaterally entered into the right 
lateral ventricle of the brain with a depth of 3 mm and 
was linked to the screws by dental cement; then, the 
rats were placed in separate cages.  
The animals were expected to recover seven days 
after the surgery. ICV injection was performed by 
Hamilton syringe (volume 100 μl). In all the groups, 
chronic pain was induced by formalin test. Formalin 
test is a valuable model for the measurement of 
chronic pain induced by a chemical stimulus (23). 
Formalin test can be divided into two phases, each of 
which demonstrating a different aspect of pain. The 
first phase or acute phase of pain occurs immediately 
after drug injection (0-7 minutes). This pain arises 
from stimulation of peripheral receptors and tissue 
destruction caused by the activation of C-type nerve 
fibers against the environmental stimuli.  
The interphase stage begins at minutes 8-14 and the 
pain behaviors diminish or disappear at this stage. The 
second or delayed phase occurs at minutes 15-60. In 
this phase, chronic pain, which is caused by 
stimulation of peripheral nerves, increased sensitivity 
of central neurons, as well as functional and 
histological alterations in the posterior grey column, is 
mild (23). To perform formalin test, 50 µl formalin 
with 2% concentration was subcutaneously injected to 
the left front paw of the rats, using needle number 31. 
The rats were placed in a formalin chamber (a 
transparent plastic container with dimensions of 40 × 
40 × 40 cm) immediately after the injection. A mirror 
was embedded on the floor of the chamber at an angle 
of 45 degrees. Observable behaviors associated with 
pain were evaluated during 0-60 minutes, and scores 
were recorded every fifteen seconds.
Under normal conditions, the animal puts its paws 
on the ground; however, behaviors associated with 
pain were observed immediately after formalin 
injection. Score 0 was given to the animals putting 
their paws completely on the floor. Score 1 was 
assigned when the animals putting their paw lightly on 
the floor. Score 2 was given to the animals that 
completely elevated their paw from the floor. Finally, 
score 3 was given to animals that began to lick and bite 
the injected paw. Afterwards, the mean scores at one 
and three minutes were recorded. All the scores were 
given solely by one person (24).
Formalin test was conducted on a daily basis, from 
9 am to 12 pm. The test was performed for two weeks 
in the first, second, and third groups, while it was 
carried out for one week in the fourth and fifth groups. 
In addition, formalin test was performed for one week 
in the sixth and seventh groups with respect to timing 
of surgery and recovery in both groups. The week was 
chosen based on recovery from cannulation by 
stereotactic apparatus. This study focused on the 
second phase of pain (chronic pain); therefore, the 
mean pain scores (at 15 to 60 minutes) were compared 
in different groups. All the rats were sacrificed by deep 
anesthesia with chloroform two hours following the 
completion of the test. Then, methylene blue 1% (50 
μl) was injected via guide cannula and the rats' brain 
was removed from the skull and was placed in 4% 
paraformaldehyde solution. The insertion site of 
cannula to the right lateral ventricle of the brain was 
observed by loupe microscope after one week. If the 
cannula location was incorrect, the animal was 
excluded from the study (24). Finally, data were 
recorded in Graph-Pad PRISM 6.01 software. One-
way ANOVA and Fisher's LSD post-hoc test were run 
using SPSS, version and p<0.05 was considered 
statistically significant 
 
 
Results 
Pain behavior induced by formalin injection: Severe 
pain behaviors secondary to formalin injection were 
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observed in all the pain phases (phases one and two as 
well as interphase). Figure 1 demonstrates pain 
behaviors induced by formalin injection in the control 
group, 0-60 minutes after the injection. Based on the 
recorded three-minute mean scores of the formalin test, 
20 sections were obtained. Sections one and two 
represent the first phase, sections three, four, and five 
represent interphase, and sections 6-20 exhibit the 
second phase or chronic pain (fig 2). 
 
 
 
 
 
 
 
Figure 1. Pain behaviors 60 minutes after formalin 
injection in the control group (normal saline) based on 
one-minute mean scores (from minutes 0-7 in the first phase, 
minutes 8-14 in the interphase in which pain behaviors reduced, 
from minutes 15-60 in the second or delayed phase) 
 
 
 
 
 
 
Figure 2. Pain behaviors 60 minutes after after 
formalin injection in the control group (normal saline) 
based on three-minute mean scores; 1 and 2 phase one, 3, 4, and 5 
interphase, and from minute 6 to 20 the second or delayed phase 
The agonist and antagonist effects of alpha-2 
adrenergic receptors on the chronic pain caused by 
formalin injection: clonidine injection alone at a dose 
of 0.7 mg/kg led to significant reduction of pain 
behavior mean score in the chronic phase compared to 
the control group (1.56±0.14 vs. 2.15±0.10; p<0.001). 
Normal saline injection could not significantly affect 
pain. However, clonidine, as an alpha-2 adrenergic 
receptor agonist, had analgesic effect on the rats; 
hence, the rats felt less pain. ICV injection of 
yohimbine as an alpha-2 adrenergic receptor antagonist 
at a dose of 1 mg/kg, before clonidine injection, 
significantly reduced the analgesic effect of clonidine 
(p<0.001; fig 3). The use of DMSO (volume 5 μl) did 
not affect pain. DMSO group was considered as the 
control group for ICV injection of yohimbine group, 
since DMSO is yohimbine solvent. The comparison of 
DMSO and normal saline groups showed that there 
was not a significant difference between the two 
groups. In addition, the comparison of ICV injection of 
yohimbine group with DMSO group showed that there 
was not a significant difference between the two 
groups (p<0.05). In contrast, the comparison of ICV 
injection of yohimbine and clonidine groups 
demonstrated a significant difference (p<0.001). In 
addition, the obtained results of this study showed a 
significant difference between the IP and ICV 
yohimbine injection groups (p<0.001). This finding 
suggests that pain in the IP yohimbine group was more 
severe than the ICV yohimbine group (fig 3).
The inhibitory effects of BK channels on chronic 
pain and the analgesia caused by alpha-2 
adrenergic receptor agonist based on formalin test: 
compared to the control group, a significant increase in 
the second phase (chronic pain) was observed in the 
ICV injection of iberiotoxin group (p<0.001). Severe 
pain behaviors were observed in the ICV injection of 
iberiotoxin+clonidine group, which was significantly 
different from the control group (p<0.001). The 
severity of pain was more in ICV injection of 
iberiotoxin+clonidine group compared to the control 
group. The comparison of the groups receiving 
iberiotoxin and iberiotoxin+clonidine with the 
clonidine group showed a significant difference 
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between them, signifying analgesic effect of clonidine. 
However, the rats in the iberiotoxin and 
iberiotoxin+clonidine groups showed severe pain 
behaviors (fig 4).  
Also, there was a significant difference between 
iberiotoxin and iberiotoxin+clonidine groups, that is, 
the rats in iberiotoxin group had severe pain, while in 
the iberiotoxin+clonidine group the pain was decreased 
(p<0.01) (fig 4). 
 
 
 
 
 
 
Figure 3. The effect of alpha-2 adrenergic receptors 
on pain: group 1: 1 ml/kg IP normal saline, group 2: 0.7 mg/kg IP 
clonidine, group 3: 1 mg/kg IP yohimbine+0.7 mg/kg IP clonidine, 
group 4: 5 μl ICV DMSO, group 5: ICV injection of 5 μg/kg 
yohimbine+0.7 mg/kg IP clonidine (n=15). ****Significantly 
different from the clonidine group (p<0.001) 
 
 
 
 
 
 
Figure 4. Analgesic mechanisms of alpha-2 
adrenergic receptor 
The comparison of clonidine (IP at a dose of 0.7 mg/kg), iberiotoxin 
(ICV at a dose of 100 nm), iberiotoxin (ICV at a dose of 100 
nm)+clonidine (IP at a dose of 70 mg/kg), and normal saline (IP 
injection ) groups (n=15) Mean±SEM. ** p<0.01, **** p<0.001 
Discussion 
According to our results, BK potassium channels 
play an important role in the analgesic effects of alpha-
2 adrenergic receptor agonists. It was found that 
clonidine, as an alpha-2 adrenergic receptor agonist, 
induced analgesic effect in rats, which was in 
accordance with the findings of similar studies (25). 
Yohimbine as an alpha-2 adrenergic receptor 
antagonist inhibited the analgesic effect of clonidine. 
In agreement with our results, former studies 
demonstrated that normal saline and DMSO did not 
have a significant effect on rats' pain after formalin 
test. The analgesic effect of clonidine alone or in 
combination with other drugs was demonstrated in 
previous studies, as well (26-32). Various routes of 
administration (e.g., intrathecal, epidural, and topical 
ointment) were employed for clonidine, and its 
analgesic effect was confirmed in several studies (33-
35). Our results indicated that yohimbine, as an alpha-
2 adrenergic receptor antagonist, did not have any 
analgesic effects. After administering yohimbine, 
alpha-2 adrenergic receptors were inhibited; thus, 
injection of clonidine following IP and ICV injection 
of yohimbine failed to show any analgesic effects. 
These results are consistent with those of other studies 
(36, 37).  
This study showed that the rats in the group 
receiving IP injection of yohimbine sustained a higher 
level of pain, compared to the group receiving ICV 
injection of yohimbine. This finding suggests that 
alpha-2 adrenergic receptors were inhibited in the 
group receiving IP injection of yohimbine; therefore, 
the analgesic effect of clonidine was completely 
controlled. However, in the group receiving ICV 
injection of yohimbine, only central alpha-2 adrenergic 
receptors were antagonized and the analgesic effect of 
clonidine was partially observed. Thus, less pain was 
observed in the group receiving ICV injection of 
yohimbine. According to the present study, BK 
channel inhibitor iberiotoxin (38) could promote pain 
in the rats.  
In addition, the inhibition of BK potassium 
channels controlled analgesic effect of clonidine as an 
alpha-2 adrenergic receptor agonist. The current study 
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exhibited that the inhibition of BK channels by 
iberiotoxin impeded analgesic effect in the rats 
receiving ICV injection of clonidine following 
iberiotoxin injection. Therefore, the rats showed pain-
related behaviors. Given the extensive distribution of 
BK potassium channels in the central nervous system 
(39, 40), Bk channels are associated with pain, which 
was confirmed by other studies (16, 18). Stimulation of 
these channels increases outward potassium current 
and hyperpolarization of cellular membrane potential 
(16, 18).  
Moreover, the severity of pain in the group 
receiving IP injection of clonidine after ICV injection 
of iberiotoxin was lower than that of the group 
receiving ICV injection of iberiotoxin alone. This 
result indicates that pain was partially controlled by 
clonidine despite inhibiting its analgesic effect by 
iberiotoxin. These findings suggest that the analgesic 
effect of clonidine can affect pain through other 
pathways, except for BK potassium channels. The role 
of BK potassium channels is recognized in the 
analgesic effect of alpha-2 adrenoceptor agonists, as 
was confirmed by previous studies and the current 
findings (11, 18). Clonidine and other alpha-2 
adrenoceptor agonists lead to hyperpolarization of 
cellular membrane through potassium channels (41). 
According to our findings and those of previous 
studies, evaluation of the potassium channels can be 
helpful in understanding pain mechanism and might 
provide a deeper insight into pain treatment in clinical 
practice (42-44). Alpha-2 adrenergic receptor agonists 
have analgesic effect on animals and its antagonists 
inhibit the analgesic effect of the receptor. Moreover, 
inhibition of BK potassium channels impedes 
analgesic effect of the receptors. 
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